Drug-Gene Testing: Key to Safer Cancer Treatment

Although the healthcare industry has a long way to go before PGx testing for DPYD and other genes becomes widespread, it’s encouraging that regulatory bodies and professional organizations are making recommendations and raising awareness among healthcare providers. The post Drug-Gene Testing: Key to Safer Cancer Treatment appeared first on MedCity News.

Read More

Rising Costs & Medicare Advantage Flaws to Drive Healthcare Reform Talks in 2026

Rising healthcare costs and flaws in the Medicare Advantage program are likely to dominate healthcare reform discussions in 2026, according to one PitchBook analyst. Potential policy changes could focus on improving affordability in the ACA market and fixing distorted incentives in Medicare Advantage. The post Rising Costs & Medicare Advantage Flaws to Drive Healthcare Reform…

Read More